Vaccine shortages: Why they occur and what needs to be done to strengthen vaccine supply

Pediatrics

Volumn 117, Issue 6, 2006, Pages 2269-2275

  Klein, Jerome O ^a,d   Myers, Martin G ^b,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c National Network for Immunization Information   (United States)

^d BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; INFLUENZA VACCINE; LYME DISEASE VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; ROTAVIRUS VACCINE; TETANUS TOXOID; TRIPLE VACCINE; VACCINE;

ARTHRITIS; DRUG CONJUGATION; DRUG COST; DRUG MANUFACTURE; DRUG PURIFICATION; FOOD AND DRUG ADMINISTRATION; HEALTH PROGRAM; HUMAN; IMMUNIZATION; NOTE; PRIORITY JOURNAL; PURCHASING; VACCINE PRODUCTION; ARTICLE; CHILD; ECONOMICS; STANDARD; UNITED STATES;

CHILD; HUMANS; UNITED STATES; VACCINES;

EID: 33745313548     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2005-2427     Document Type: Note

References (13)

1. Santoli JM, Peter G, Arvin AM, et al. Strengthening the supply of routinely recommended vaccines in the United States: recommendations from the National Vaccine Advisory Committee. JAMA. 2004;290:3122-3128
2. Klein JO, guest ed. Strengthening the supply of routinely administered vaccines in the United States: presentations at workshops convened by the National Vaccine Advisory Committee, Department of Health and Human Services, February 2002 and January 2005. Clin Infect Dis. 2006;42(suppl 3): S97-S150
3. US General Accounting Office. Childhood vaccines: ensuring an adequate supply poses continuing challenges. September 2002. Available at: www.gao.gov/new.items/d02987.pdf. Accessed March 24, 2006
4. Albert B. Sabin Vaccine Institute. Feasible solutions to global vaccine shortages: proceedings of the Albert B. Sabin Vaccine Institute Tenth Annual Vaccine Colloquium. 2004. Available at: www.sabin.org/PDF/CSH2003final.pdf. Accessed March 24, 2006
5. Institute of Medicine. Financing Vaccines in the 21st Century: Assuring Access and Availability. Washington, DC: The National Academies Press; 2004
6. Iglehart NK, ed. The vaccine enterprise. Health Aff (Millwood). 2005;24(special issue):594-769
7. Paradiso PR. A look at pediatric vaccine development. Contemp Pediatr. 2003:4-6
8. Hensley S, Temoriero H, Greil A. Pfizer, Wyeth report 2nd quarter gains. Wall Street Journal. July 20, 2005:B2
9. Hinman AR, Orenstein WA, Rodewald L. Financing immunizations in the United States. Clin Infect Dis. 2004;38:1440-1446
10. Stratton K, Gable A, Shetty P, McCormick MC, eds. Immunization Safety Review: Measles, Mumps, Rubella Vaccine and Autism. Washington, DC: National Academy Press; 2001
11. Stratton K, Gable A, McCormick MC, eds. Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders. Washington, DC: National Academy Press; 2001
12. Glazner JE, Beaty BL, Pearson KA, Berman S. The cost of giving childhood vaccinations: differences among provider types. Pediatrics. 2004;113:1582-1587
13. US Department of Health and Human Services. Pandemic planning update. Available at: www.pandemicflu.gov. Accessed April 5, 2006